ABSTRACT
OBJECTIVE: Osteoarthritis is a condition characterized by articular cartilage degradation. The increased expression of ß1,4-Galactosyltransferase-I (ß1,4-GalT-I) in the articular cartilage of osteoarthritis patients was related to an inflammatory response. The aim of this study was to elucidate the role of ß1,4-GalT-I in osteoarthritis. This study aimed to determine the function of 1,4-GalT-I in osteoarthritis. METHODS: The osteoarthritis mouse model with the destabilization of the medial meniscus was established by microsurgical technique. Pathological changes in articular cartilage were observed by hematoxylin and eosin staining and safranin O-fast green staining. Quantitative real-time polymerase chain reaction, western blot, and enzyme-linked immunosorbent assays were used to observe mRNA and protein expression, respectively. RNA interactions were verified by a luciferase reporter assay. SA-ß-Gal staining was used to assess chondrocyte senescence. Immunofluorescence staining was conducted to observe the localization of Nuclear Factor-kappaB (NF-κB). RESULTS: ß1,4-GalT-I and microRNA-15a (miR-15a) show high and low expression in the articular cartilage of osteoarthritis, respectively. MiR-15a inhibits the mRNA translation of ß1,4-GalT-I. ß1,4-GalT-I promotes extracellular matrix degradation, senescence, and NF-κB activation in IL-1ß-stimulated chondrocytes, which can be reversed by overexpression of miR-15a. Intra-articular injection of microRNA-15a ameliorates cartilage degeneration by inhibiting ß1,4-GalT-I and phosphorylation of NF-κB in vivo. CONCLUSION: The authors clarified that the miR-15a/ß1,4-GalT-I axis inhibits the phosphorylation of NF-κB thereby inhibiting extracellular matrix degradation and senescence in chondrocytes to alleviate cartilage degeneration in osteoarthritis. MiR-15a and ß1,4-GalT-I may serve as potentially effective targets for the future treatment of osteoarthritis.
Subject(s)
Cartilage, Articular , MicroRNAs , Osteoarthritis , Animals , Mice , Cartilage, Articular/pathology , Chondrocytes/pathology , Interleukin-1beta , MicroRNAs/genetics , NF-kappa B/metabolism , Osteoarthritis/genetics , Signal TransductionABSTRACT
Osteoarthritis (OA) is a whole-joint disease primarily characterized by the deterioration of hyaline cartilage. Current treatments include microfracture and chondrocyte implantation as early surgical strategies that can be combined with scaffolds to repair osteochondral lesions; however, intra-articular (IA) injections or implantations of mesenchymal stem cells (MSCs) are new approaches that have presented encouraging therapeutic results in animal models and humans. We critically reviewed clinical trials with MSC therapies for OA, focusing on their effectiveness, quality, and outcomes in the regeneration of articular cartilage. Several sources of autologous or allogeneic MSCs were used in the clinical trials. Minor adverse events were generally reported, indicating that IA applications of MSCs are potentially safe. The evaluation of articular cartilage regeneration in human clinical trials is challenging, particularly in the inflammatory environment of osteoarthritic joints. Our findings indicate that IA injections of MSCs are efficacious in the treatment of OA and the regeneration of cartilage, but that they may be insufficient for the full repair of articular cartilage defects. The possible interference of clinical and quality variables in the outcomes suggests that robust clinical trials are still necessary for generating reliable evidence with which to support these treatments. We suggest that the administration of just-sufficient doses of viable cells in appropriate regimens is critical to achieve effective and durable effects. In terms of future perspectives, genetic modification, complex products with extracellular vesicles derived from MSCs, cell encapsulation in hydrogels, and 3D bioprinted tissue engineering are promising approaches with which to improve MSC therapies for OA.
Subject(s)
Cartilage, Articular , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells , Osteoarthritis , Animals , Humans , Cartilage, Articular/pathology , Osteoarthritis/therapy , Osteoarthritis/pathology , Chondrocytes/pathology , Mesenchymal Stem Cells/pathology , Tissue Engineering , Mesenchymal Stem Cell Transplantation/methodsABSTRACT
INTRODUCTION: The association between triamcinolone hexacetonide (TH) and gold nanoparticles (GNPs) represents a promising treatment due to the potential anti-inflammatory and antioxidant effects of these compounds. In this study, we evaluated the effects of intra-articular treatment of TH associated with GNPs in a mechanical model of osteoarthritis (OA). METHODS: Fifty Wistar rats were divided into five groups: Sham; OA; OA+TH; OA+GNPs; OA+TH-GNPs. Both applications were performed 30 and 60 days after the model was induced. After 30 days of the last application, the animals were euthanized. RESULTS: Only the combined treatment with TH and GNPs promoted a reduction in proinflammatory cytokines and an increase in anti-inflammatory cytokines. The OA+TH-GNPs group obtained a significant reduction in the production of oxidants and oxidative damage markers while an increase in antioxidants. Histologically, all treated groups showed results of a significant increase in cartilage thickness and chondrocyte count, the OA+TH-GNPs group had similar behavior to the group without osteoarthritis, with significantly smaller amounts of chondrocytes than the OA group. CONCLUSION: The intra-articular use of TH associated with GNPs may be able to prevent the progression of the pathology and minimize joint degradation.
Subject(s)
Cartilage, Articular , Metal Nanoparticles , Osteoarthritis , Rats , Animals , Gold , Rats, Wistar , Cartilage, Articular/metabolism , Osteoarthritis/metabolism , Models, Animal , Antioxidants/pharmacology , Antioxidants/therapeutic use , Antioxidants/metabolism , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Anti-Inflammatory Agents/metabolism , Cytokines/metabolism , Chondrocytes/metabolism , Chondrocytes/pathologyABSTRACT
The purpose of this study is to evaluate the effects of photobiomodulation (PBM) therapy in chondrocyte response by in vitro experiments and cartilage repair using an experimental model of osteoarthritis (OA) in the knee of rats. The in vitro experiment was performed with chondrocyte cells, and they were divided into two groups: non-irradiated and irradiated with PBM (808 nm; 0.8 J or 1.4 J). Then, cell proliferation was evaluated after 1, 3, and 5 days. The experimental model of osteoarthritis (OA) was performed in the knee of 64 Wistar rats, and they were assorted into control group (CG), PBM (808 nm; 1.4 J). The results of in vitro showed that PBM 1.4 J increased cell proliferation, on days 1 and 5. However, after 3 days was demonstrated a significant increase in cell proliferation in PBM 0.8 J. The in vivo experiment results demonstrated, on histological analysis, that PBM presented less intense signs of tissue degradation with an initial surface discontinuity at the superficial zone and disorganization of the chondrocytes in the cartilage region when compared to CG, after 4 and 8 weeks. These findings were confirmed by immunohistochemistry and qRT-PCR analysis which showed that PBM increased IL-4, IL-10, COL-2, Aggrecan, and TGF-ß which are anabolic factors and acts on extracellular matrix. Also, PBM reduces the IL1-ß, an inflammatory marker that operates as a catabolic factor on articular cartilage. In conclusion, these results suggest that PBM may have led to a return to tissue homeostasis, promoting chondroprotective effects and stimulating the components of the articular tissue.
Subject(s)
Cartilage, Articular , Low-Level Light Therapy , Osteoarthritis, Knee , Osteoarthritis , Animals , Cartilage, Articular/pathology , Chondrocytes/pathology , Disease Models, Animal , Osteoarthritis/genetics , Osteoarthritis/metabolism , Osteoarthritis/radiotherapy , Osteoarthritis, Knee/genetics , Osteoarthritis, Knee/radiotherapy , Rats , Rats, WistarABSTRACT
This study investigated the effects of aging on the articular cartilage of the mandible. Wistar rats were divided in two groups (n = 10/per group): 3-months-old group (young group); and 13-months-old group (aged group). After euthanasia, the head of the mandible was collected and stained with hematoxylin and eosin (HE) to evaluate the thickness of the articular layer and cartilage. Sections stained with Picrosirius red and Safranin O were used to evaluate the collagen and proteoglycans deposition, respectively. First, aging has decreased the articular layer thickness. Second, the results suggest a decrease of chondrocytes followed by an increase of the matrix to maintain the mandible homeostasis. Finally, both collagen and proteoglycans increased with aging. Aging displayed important effects to the mandible of aged rats.
Subject(s)
Age Factors , Cartilage, Articular/metabolism , Chondrocytes/metabolism , Collagen/metabolism , Animals , Cartilage, Articular/pathology , Chondrocytes/pathology , Male , Mandible/pathology , Proteoglycans/metabolism , Rats, WistarABSTRACT
The aim of this study was to evaluate the effects of low-level laser therapy using the gallium arsenide laser (λ = 830 nm) on the articular cartilage (AC) organization from knee joint in an experimental model of microcrystalline arthritis in adult male Wistar rats. Seventy-two animals were divided into three groups: A (control), B (induced arthritis), and C (induced arthritis + laser therapy). The arthritis was induced in the right knee using 2 mg of Na4P2O7 in 0.5 mL of saline solution. The treatments were daily applied in the patellar region of the right knee after 48 h of induction. On the 7th, 14th, and 21st days of treatment, the animals were euthanized and their right knees were removed and processed for structural and biochemical analysis of the AC. The chondrocytes positively labeled for the TUNEL reaction were lower in C than in B on the 14th and 21st days. The content of glycosaminoglycans and hydroxyproline in A and C was higher than B on the 21st day. The amount of tibial TNF-α in B and C was lower than in A. The amount of tibial BMP-7 in B and C was higher than in A. The femoral MMP-13 was lower in B and C than for A. The tibial TGF-ß for C was higher than the others. The femoral ADAMT-S4 content of A and C presented similar and inferior data to B on the 21st day. The AsGa-830 nm therapy preserved the content of glycosaminoglycans, reduced the cellular changes and the inflammatory process compared to the untreated group.
Subject(s)
Arthritis, Experimental/radiotherapy , Cartilage, Articular/pathology , Cartilage, Articular/radiation effects , Low-Level Light Therapy , ADAMTS4 Protein/metabolism , Animals , Apoptosis/radiation effects , Arthritis, Experimental/pathology , Bone Morphogenetic Protein 7/metabolism , Cartilage, Articular/ultrastructure , Chondrocytes/pathology , Chondrocytes/radiation effects , Disease Models, Animal , Femur/pathology , Femur/radiation effects , Male , Matrix Metalloproteinase 13/metabolism , Rats, Wistar , Tibia/pathology , Tibia/radiation effects , Tibia/ultrastructure , Transforming Growth Factor beta/metabolismABSTRACT
The in vitro process of chondrogenic differentiation of mesenchymal stem cells (MSCs) induces a pre-apoptotic hypertrophic phenotype, guided by the active status of the WNT/ßcatenin pathway. To achieve a stable chondrocyte phenotype for cartilage tissue engineering, it is necessary to gain a better understanding of specific genes that regulate the cartilage tissue phenotype. RNA sequencing (RNA-seq) analysis of tissue samples from bone, cartilage, growth plate and muscle show that Dickkopf-1 (DKK1), a natural WNT canonical signaling inhibitor, is expressed in cartilage tissue. This observation reinforces the concept that inhibition of the WNT/ßcatenin pathway is critical for preventing avoid chondrocyte hypertrophy in vitro. We used two doses of DKK1 in a pellet cell culture system to inhibit the terminal differentiation of chondrocytes derived from bone marrow mesenchymal stem cells (MSCs). Bone marrow MSCs were cultured in chondrogenic induction medium with 50 and 200â¯ng/ml of DKK1 for 21â¯days. The highest doses of DKK1 reduce ßcatenin expression and nuclear localization at day 21, concomitant with reduced expression and activity of hypertrophy markers collagen type X (COL10A1) and alkaline phosphatase (ALPL), thus decreasing the pre-hypertrophic chondrocyte population. Furthermore, DKK1 stimulated expression of collagen type II (COL2A1) and glycosaminoglycans (GAGs), which represent healthy articular cartilage markers. We conclude that exogenous DKK1 impedes chondrocyte progression into a prehypertrophic stage and stimulates expression of healthy articular cartilage markers by blocking the WNT/ßcatenin pathway. Hence, DKK1 may promote a mature healthy articular cartilage phenotype and facilitate cartilage tissue engineering for joint repair.
Subject(s)
Biomarkers/analysis , Bone Marrow Cells/pathology , Chondrocytes/pathology , Chondrogenesis , Hypertrophy/pathology , Intercellular Signaling Peptides and Proteins/metabolism , Mesenchymal Stem Cells/pathology , Adult , Apoptosis , Bone Marrow Cells/metabolism , Cell Differentiation , Cell Proliferation , Cells, Cultured , Chondrocytes/metabolism , Female , Humans , Hypertrophy/metabolism , Intercellular Signaling Peptides and Proteins/genetics , Male , Mesenchymal Stem Cells/metabolism , Tissue Engineering , Young AdultABSTRACT
OBJECTIVE: This study aimed to develop a new histological scoring system for use in a partial-thickness cartilage repair animal model. Although previous papers have investigated the regeneration of articular cartilage, the good results achieved in small animals have not been replicated in large animal models or humans, possibly because of the frequent use of models with perforation of the subchondral bone plates. Partial-thickness lesions spare the subchondral bone, and this pattern is the most frequent in humans; therefore, new therapies should be tested using this model. However, no specific histological score exists to evaluate partial-thickness model results. METHODS: Histological sections from 30 ovine knees were reviewed to develop a new scoring system. The sections were subjected to H&E, Safranin O, and Masson's trichrome staining. RESULTS: This paper describes a new scoring tool that is divided into sections in detail: repair of tissue inside the lesion, cartilage around the lesion and degenerative changes at the base of the lesion. Scores range from 0 to 21; a higher score indicates better cartilage repair. DISCUSSION: Unlike existing tools, this new scale does not assign points for the positioning of a tidemark; we propose evaluation of the degenerative changes to the subchondral bone and calcified cartilage layer. It is necessary to remove the whole joint to access and study the evolution of the lesion as well as the surrounding tissue. CONCLUSION: This article emphasizes the importance of a partial-thickness animal model of cartilage repair and presents a new histological scoring system.
Subject(s)
Cartilage, Articular/injuries , Cartilage, Articular/pathology , Disease Models, Animal , Regeneration/physiology , Tissue Engineering/methods , Animals , Biopsy , Bone and Bones/pathology , Bone and Bones/physiology , Cartilage Diseases/pathology , Cartilage Diseases/physiopathology , Chondrocytes/pathology , Chondrocytes/physiology , Hindlimb , Reference Standards , Reproducibility of Results , Sheep , Time FactorsABSTRACT
The aim of this study was to evaluate the biostimulation (BS) effect of the gallium-aluminum-arsenide (GaAlAs) diode laser by histopathology with an experimental osteoarthritis (OA) model in the temporomandibular joints (TMJ) of rabbits, in the early period. GaAlAs diode laser is used for pain reduction in TMJ disorders. Twenty-four adult male New Zealand white rabbits were randomly divided into three equal groups: Control Group (CG), Study Group 1 (SG-1), and Study Group 2 (SG-2). Mono-iodoacetate (MIA) was administered to the right TMJs of all rabbits. The rabbits did not undergo any treatment for four weeks to allow the development of osteoarthritis. In SG-1, laser BS was applied to the rabbits at 940 nm, 5 W, and 15 J/cm2 in continuous wave mode at 48-hour intervals for 14 sessions; and in SG-2, laser BS was applied with the same parameters at 24-hour intervals for 28 sessions. Laser BS was not applied to the rabbits in CG. All rabbits were sacrificed simultaneously. The TMJ cartilage, osteochondral junction, chondrocyte appearance, and subchondral ossification were evaluated histopathologically. There was no statistically significant difference between the groups in terms of cartilage, osteochondral junction, chondrocyte appearance, and subchondral ossification values (p > 0.05). The laser BS protocol used in the study had no positive histopathological effects on TMJ OA in the early period.
Subject(s)
Lasers, Semiconductor/therapeutic use , Low-Level Light Therapy/methods , Osteoarthritis/radiotherapy , Temporomandibular Joint Disorders/radiotherapy , Animals , Chondrocytes/pathology , Chondrocytes/radiation effects , Male , Osteoarthritis/pathology , Rabbits , Reproducibility of Results , Temporomandibular Joint/pathology , Temporomandibular Joint Disorders/pathology , Treatment OutcomeABSTRACT
The aim of this study was to compare the effects of combined treatment with chondroitin sulfate and glucosamine sulfate (CS/Gl) and photobiomodulation (PBM) on the degenerative process related to osteoarthritis (OA) in the articular cartilage in rats. Forty male Wistar rats were randomly divided into four groups: OA control group (CG); OA animals submitted to PBM treatment (PBM); OA animals submitted to CS/Gl treatment (CS/Gl); OA submitted to CS/GS associated with PBM treatments (GS/Gl + PBM). The CS/Gl started 48 h after the surgery, and they were performed for 29 consecutive days. Moreover, PBM was performed after the CS/Gl administration on the left joint. Morphological characteristics and immunoexpression of interleukin 10 (IL-10) and 1 beta (IL-1ß) and collagen type II (Col II) of the articular cartilage were evaluated. The results showed that all treated groups (CS/Gl and PBM) presented attenuation signs of degenerative process (measured by histopathological analysis) and lower density chondrocytes [PBM (p = 0.0017); CS/Gl (p = 0.0153) and CS/Gl + PBM (p = 0.002)]. Additionally, CS/Gl [associated (p = 0.0089) or not with PBM (p = 0.0059)] showed significative lower values for OARSI grade evaluation. Furthermore, CS/GS + PBM decreased IL-1ß protein expression (p = 0.0359) and increased IL-10 (p = 0.028) and Col II imunoexpression (p = 0.0204) compared to CG. This study showed that CS/Gl associated with PBM was effective in modulating inflammatory process and preventing the articular tissue degradation in the knees OA rats.
Subject(s)
Chondroitin Sulfates/therapeutic use , Glucosamine/therapeutic use , Low-Level Light Therapy , Osteoarthritis/drug therapy , Osteoarthritis/pathology , Osteoarthritis/radiotherapy , Animals , Chondrocytes/drug effects , Chondrocytes/pathology , Chondrocytes/radiation effects , Chondroitin Sulfates/pharmacology , Collagen Type II/metabolism , Combined Modality Therapy , Disease Models, Animal , Glucosamine/pharmacology , Immunohistochemistry , Interleukin-10/metabolism , Interleukin-1beta/metabolism , Male , Osteoarthritis/metabolism , Rats, WistarABSTRACT
Purpose/Aim: The aim of this study was to evaluate the effects of excess maternal and postnatal thyroxine on chondrocytes and the extracellular matrix (ECM) of growth cartilage. MATERIALS AND METHODS: We used 16 adult female Wistar rats divided into two groups: thyroxine treatment and control. From weaning to 40 days of age, offspring of the treated group (n = 8) received L-thyroxine. Plasma free T4 was measured. Histomorphometric analysis was performed on thyroids and femurs of all offspring. Alcian blue histochemical staining and real-time reverse transcription polymerase chain reaction measurements of gene expression levels of Sox9, Runx2, Aggrecan, Col I, Col II, Alkaline phosphatase, Mmp2, Mmp9, and Bmp2 were performed. Data were analyzed for statistical significance by student's t-test. RESULTS: Excess maternal and postnatal thyroxine reduced the intensity of Alcian blue staining, altered the number of chondrocytes in proliferative and hypertrophic zones in growth cartilage, and reduced the gene expression of Sox9, Mmp2, Mmp9, Col II, and Bmp2 in the growth cartilage of all offspring. Additionally, excess thyroxine altered the gene expression of Runx2, Aggrecan and Col I, and this effect was dependent on age. CONCLUSIONS: Excess thyroxine in neonates suppresses chondrocyte proliferation, stimulates chondrocyte hypertrophy and changes the ECM composition by reducing the amount of proteoglycans and glycosaminoglycans (GAGs). Prolonged exposure to excess thyroxine suppresses chondrocyte activity in general, with a severe reduction in the proteoglycan content of cartilage and the expression of gene transcripts essential for endochondral growth and characteristics of the chondrocyte phenotype.
Subject(s)
Cartilage/growth & development , Cell Proliferation/drug effects , Chondrocytes/metabolism , Extracellular Matrix/metabolism , Prenatal Exposure Delayed Effects/metabolism , Thyroxine/adverse effects , Animals , Cartilage/pathology , Chondrocytes/pathology , Extracellular Matrix/pathology , Female , Femur/growth & development , Femur/pathology , Gene Expression Regulation/drug effects , Pregnancy , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/pathology , Rats , Rats, Wistar , Thyroxine/pharmacologyABSTRACT
OBJECTIVE: This study aimed to develop a new histological scoring system for use in a partial-thickness cartilage repair animal model. Although previous papers have investigated the regeneration of articular cartilage, the good results achieved in small animals have not been replicated in large animal models or humans, possibly because of the frequent use of models with perforation of the subchondral bone plates. Partial-thickness lesions spare the subchondral bone, and this pattern is the most frequent in humans; therefore, new therapies should be tested using this model. However, no specific histological score exists to evaluate partial-thickness model results. METHODS: Histological sections from 30 ovine knees were reviewed to develop a new scoring system. The sections were subjected to H&E, Safranin O, and Masson's trichrome staining. RESULTS: This paper describes a new scoring tool that is divided into sections in detail: repair of tissue inside the lesion, cartilage around the lesion and degenerative changes at the base of the lesion. Scores range from 0 to 21; a higher score indicates better cartilage repair. DISCUSSION: Unlike existing tools, this new scale does not assign points for the positioning of a tidemark; we propose evaluation of the degenerative changes to the subchondral bone and calcified cartilage layer. It is necessary to remove the whole joint to access and study the evolution of the lesion as well as the surrounding tissue. CONCLUSION: This article emphasizes the importance of a partial-thickness animal model of cartilage repair and presents a new histological scoring system.
Subject(s)
Animals , Regeneration/physiology , Cartilage, Articular/injuries , Cartilage, Articular/pathology , Tissue Engineering/methods , Disease Models, Animal , Reference Standards , Time Factors , Biopsy , Bone and Bones/physiology , Bone and Bones/pathology , Sheep , Cartilage Diseases/physiopathology , Cartilage Diseases/pathology , Reproducibility of Results , Chondrocytes/physiology , Chondrocytes/pathology , HindlimbABSTRACT
Abstract The aim of this study was to evaluate the biostimulation (BS) effect of the gallium-aluminum-arsenide (GaAlAs) diode laser by histopathology with an experimental osteoarthritis (OA) model in the temporomandibular joints (TMJ) of rabbits, in the early period. GaAlAs diode laser is used for pain reduction in TMJ disorders. Twenty-four adult male New Zealand white rabbits were randomly divided into three equal groups: Control Group (CG), Study Group 1 (SG-1), and Study Group 2 (SG-2). Mono-iodoacetate (MIA) was administered to the right TMJs of all rabbits. The rabbits did not undergo any treatment for four weeks to allow the development of osteoarthritis. In SG-1, laser BS was applied to the rabbits at 940 nm, 5 W, and 15 J/cm2 in continuous wave mode at 48-hour intervals for 14 sessions; and in SG-2, laser BS was applied with the same parameters at 24-hour intervals for 28 sessions. Laser BS was not applied to the rabbits in CG. All rabbits were sacrificed simultaneously. The TMJ cartilage, osteochondral junction, chondrocyte appearance, and subchondral ossification were evaluated histopathologically. There was no statistically significant difference between the groups in terms of cartilage, osteochondral junction, chondrocyte appearance, and subchondral ossification values (p > 0.05). The laser BS protocol used in the study had no positive histopathological effects on TMJ OA in the early period.
Subject(s)
Animals , Male , Osteoarthritis/radiotherapy , Temporomandibular Joint Disorders/radiotherapy , Low-Level Light Therapy/methods , Lasers, Semiconductor/therapeutic use , Osteoarthritis/pathology , Rabbits , Temporomandibular Joint/pathology , Temporomandibular Joint Disorders/pathology , Reproducibility of Results , Treatment Outcome , Chondrocytes/radiation effects , Chondrocytes/pathologyABSTRACT
CASE REPORT: The present report describes a case of chondroblastic osteosarcoma in the periapical region of teeth #29, #30, and #31 of an 18-year-old male. Clinical history showed self-reported discomfort in the right posterior gingiva for over a month. Physical examination showed a small expansion and redness of the right mandibular buccal and lingual cortical plates, but no signs of pain or inflammation were observed. All the teeth responded positively to pulp sensibility. Periapical and panoramic radiographs showed slight periapical radiolucency in the roots of teeth #29 and #30, clear periodontal ligament space widening, and evident loss of lamina dura. Incisional biopsy was performed, and based on microscopic findings the diagnosis of chondroblastic osteosarcoma was confirmed. CONCLUSIONS: Non-endodontic diseases associated with tooth root apex, such as chondroblastic osteosarcoma, should be included in differential diagnosis of jaw lesions that resemble periapical abscess.
Subject(s)
Chondrocytes/pathology , Mandibular Neoplasms/pathology , Osteosarcoma/pathology , Periapical Abscess/pathology , Adolescent , Biopsy , Cone-Beam Computed Tomography , Diagnosis, Differential , Humans , Immunohistochemistry , Male , Mandibular Neoplasms/diagnostic imaging , Osteosarcoma/diagnostic imaging , Periapical Abscess/diagnostic imaging , Radiography, PanoramicABSTRACT
Abstract Lesions of non-endodontic origin may mimic periapical abscess. Osteosarcoma is a rare malignant lesion. Case report The present report describes a case of chondroblastic osteosarcoma in the periapical region of teeth #29, #30, and #31 of an 18-year-old male. Clinical history showed self-reported discomfort in the right posterior gingiva for over a month. Physical examination showed a small expansion and redness of the right mandibular buccal and lingual cortical plates, but no signs of pain or inflammation were observed. All the teeth responded positively to pulp sensibility. Periapical and panoramic radiographs showed slight periapical radiolucency in the roots of teeth #29 and #30, clear periodontal ligament space widening, and evident loss of lamina dura. Incisional biopsy was performed, and based on microscopic findings the diagnosis of chondroblastic osteosarcoma was confirmed. Conclusions Non-endodontic diseases associated with tooth root apex, such as chondroblastic osteosarcoma, should be included in differential diagnosis of jaw lesions that resemble periapical abscess.
Subject(s)
Humans , Male , Adolescent , Periapical Abscess/pathology , Mandibular Neoplasms/pathology , Osteosarcoma/pathology , Chondrocytes/pathology , Periapical Abscess/diagnostic imaging , Biopsy , Immunohistochemistry , Radiography, Panoramic , Mandibular Neoplasms/diagnostic imaging , Osteosarcoma/diagnostic imaging , Diagnosis, Differential , Cone-Beam Computed TomographyABSTRACT
This study aimed to analyze the effects of caloric restriction on aged femoral articular cartilage of Wistar rats. Three groups of eight animals each were considered: young (YC) and old (OC) control groups fed with a normal diet and old caloric restriction group (OCR) composed of 18-month-old animals fed with a 31% less caloric diet from 6-months of age. Articular cartilage was studied through morphometry and immunohistochemistry. Body mass was 12% less in the OCR group than in the OC group. The articular cartilage from OC rats show thinner medial condyles, fewer chondrocytes, smaller chondrocytes nuclear volume and, in both condyles, a predominance of collagen type II and less collagen density compared to both YC and OCR groups (p < .001). In contrast, OCR articular cartilage show thicker medial condyles, larger chondrocytes nuclear volume and increased collagen density compared to OC group (p < 0.001). We concluded that caloric restriction minimizes the effects of aging on medial condyles of the femoral articular cartilage.
Subject(s)
Aging/metabolism , Caloric Restriction , Cartilage, Articular/metabolism , Chondrocytes/metabolism , Femur/pathology , Aging/physiology , Animals , Cartilage, Articular/cytology , Cartilage, Articular/pathology , Chondrocytes/cytology , Chondrocytes/pathology , Collagen/metabolism , Collagen/physiology , Male , Random Allocation , Rats , Rats, WistarABSTRACT
Background: Lipoma is defined as a tumor composed of mature adipocytes, identical to the cells that form normal adult fat. Other elements may also be present, such as cartilaginous tissue. Chondrolipoma is characterized by the presence of differentiated cartilage islands spread within a typical lipoma, in which mucin and collagen can be observed around isles of chondrocytes. This condition affects mainly middle-aged or elderly dogs as well as elderly humans. In the scientific literature, chondrolipomas have not yet been described on the ear of dogs. Therefore, this study aimed to report a case of chondrolipoma on the ear of a dog and its histopathological and histochemical description. Case: A female, 10-year-old, Labrador retriever dog was admitted to the Veterinarian Hospital of the Federal University of Paraíba (UFPB), Areia, Brazil. The dog was presented with an ulcerated pendulous nodule on the ear, with a clinical evolution of approximately 7 months. A biopsy sample was taken and submitted to the Veterinary Histopathology Laboratory of the UFPB. Macroscopic evaluation revealed a pendulous and firm nodule, with a round apex, measuring 1.3cm in diameter. The epidermis covering the nodule exhibited an ulcer of 0.5cm in length. The nodule exhibited resistance to cutting and the surface was dark red with hard areas in the center. Sample was fixed in 10% formalin and routinely [...](AU)
Subject(s)
Animals , Dogs , Lipoma/diagnosis , Lipoma/veterinary , Chondrocytes/pathology , Mucins/analysis , Collagen/analysis , Alcian Blue , Ear Cartilage/pathology , Staining and Labeling/veterinaryABSTRACT
Background: Lipoma is defined as a tumor composed of mature adipocytes, identical to the cells that form normal adult fat. Other elements may also be present, such as cartilaginous tissue. Chondrolipoma is characterized by the presence of differentiated cartilage islands spread within a typical lipoma, in which mucin and collagen can be observed around isles of chondrocytes. This condition affects mainly middle-aged or elderly dogs as well as elderly humans. In the scientific literature, chondrolipomas have not yet been described on the ear of dogs. Therefore, this study aimed to report a case of chondrolipoma on the ear of a dog and its histopathological and histochemical description. Case: A female, 10-year-old, Labrador retriever dog was admitted to the Veterinarian Hospital of the Federal University of Paraíba (UFPB), Areia, Brazil. The dog was presented with an ulcerated pendulous nodule on the ear, with a clinical evolution of approximately 7 months. A biopsy sample was taken and submitted to the Veterinary Histopathology Laboratory of the UFPB. Macroscopic evaluation revealed a pendulous and firm nodule, with a round apex, measuring 1.3cm in diameter. The epidermis covering the nodule exhibited an ulcer of 0.5cm in length. The nodule exhibited resistance to cutting and the surface was dark red with hard areas in the center. Sample was fixed in 10% formalin and routinely [...]
Subject(s)
Animals , Dogs , Collagen/analysis , Chondrocytes/pathology , Lipoma/diagnosis , Lipoma/veterinary , Mucins/analysis , Alcian Blue , Ear Cartilage/pathology , Staining and Labeling/veterinaryABSTRACT
This study aimed to determine whether abnormal apoptosis is present in acetabular cartilage in early developmental dislocations of the hip (DDH), and if so, whether it is correlated with the expression of caspase-3 and Bcl-2. DDH was induced in 24 4-week-old New Zealand white rabbits. Acetabular cartilage specimens from the experimental and control groups were stained with hematoxylin and eosin (H&E). Animals from the experimental group developed acetabular dysplasia. Apoptotic chondrocytes were observed by ultrastructural electron microscopy and H&E. TUNEL assays revealed significantly greater acetabular chondrocyte apoptosis in the treated samples as compared to the control. Significantly higher caspase-3 expression and lower Bcl-2 expression were also measured in the DDH group compared with the control. We conclude that excessive apoptosis does occur in acetabular cartilage with DDH, and is positively correlated with high caspase-3 expression as well as low Bcl-2 expression.
Subject(s)
Acetabulum/pathology , Apoptosis , Caspase 3/metabolism , Chondrocytes/enzymology , Chondrocytes/pathology , Hip Dislocation/pathology , Proto-Oncogene Proteins c-bcl-2/metabolism , Acetabulum/diagnostic imaging , Animals , Cell Nucleus/ultrastructure , Cell Shape , Chondrocytes/ultrastructure , Femur Head/pathology , Hip Dislocation/diagnostic imaging , Immobilization , Immunohistochemistry , In Situ Nick-End Labeling , Rabbits , Staining and LabelingABSTRACT
The external ear is composed of elastic cartilage. Microtia is a congenital malformation of the external ear that involves a small reduction in size or a complete absence. The aim of tissue engineering is to regenerate tissues and organs clinically implantable based on the utilization of cells and biomaterials. Remnants from microtia represent a source of cells for auricular reconstruction using tissue engineering. To examine the macromolecular architecture of microtia cartilage and behavior of chondrocytes, in order to enrich the knowledge of this type of cartilage as a cell reservoir. Auricular cartilage remnants were obtained from pediatric patients with microtia undergoing reconstructive procedures. Extracellular matrix composition was characterized using immunofluorescence and histological staining methods. Chondrocytes were isolated and expanded in vitro using a mechanical-enzymatic protocol. Chondrocyte phenotype was analyzed using qualitative PCR. Microtia cartilage preserves structural organization similar to healthy elastic cartilage. Extracellular matrix is composed of typical cartilage proteins such as type II collagen, elastin and proteoglycans. Chondrocytes displayed morphological features similar to chondrocytes derived from healthy cartilage, expressing SOX9, COL2 and ELN, thus preserving chondral phenotype. Cell viability was 94.6 % during in vitro expansion. Elastic cartilage from microtia has similar characteristics, both architectural and biochemical to healthy cartilage. We confirmed the suitability of microtia remnant as a reservoir of chondrocytes with potential to be expanded in vitro, maintaining phenotypical features and viability. Microtia remnants are an accessible source of autologous cells for auricular reconstruction using tissue engineering strategies.